Literature DB >> 8299935

Suppression of activated Let-60 ras protein defines a role of Caenorhabditis elegans Sur-1 MAP kinase in vulval differentiation.

Y Wu1, M Han.   

Abstract

The let-60 ras gene of Caenorhabditis elegans is one of the key players in a signal transduction pathway that controls the choice between vulval and epidermal differentiation in response to extracellular signals. To identify components acting downstream of let-60 ras in the vulval signaling pathway, we have identified a reduction-of-function mutation in the sur-1 gene that completely suppresses the multivulva phenotype of a hyperactive let-60 ras mutation. About 10% of animals homozygous for the sur-1 mutation also display a specific and intriguing vulval cell lineage defect. In addition, the sur-1 mutation results in a cold-sensitive egg-laying defective phenotype and a partial larval lethal phenotype. We have cloned the sur-1 gene by DNA-mediated transformation and have shown that it encodes a protein similar in overall structure to mammalian MAP kinases (ERKs). The functional homology between Sur-1 MAP kinase and mammalian MAP kinases was also demonstrated by the ability of a rat ERK2 kinase to rescue the sur-1 mutant phenotypes. Genetic double-mutant analyses place sur-1 downstream of let-60 ras but upstream of lin-1 in the vulval signaling pathway. Our results provide further evidence for the extreme conservation of Ras-mediated signaling pathway between worms and humans and for the function of MAP kinases in cell signaling processes that control cell differentiation and animal development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299935     DOI: 10.1101/gad.8.2.147

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  54 in total

1.  A PP2A regulatory subunit positively regulates Ras-mediated signaling during Caenorhabditis elegans vulval induction.

Authors:  D S Sieburth; M Sundaram; R M Howard; M Han
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

Review 2.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

3.  The Nkx5/HMX homeodomain protein MLS-2 is required for proper tube cell shape in the C. elegans excretory system.

Authors:  Ishmail Abdus-Saboor; Craig E Stone; John I Murray; Meera V Sundaram
Journal:  Dev Biol       Date:  2012-04-17       Impact factor: 3.582

4.  Multiple functions and dynamic activation of MPK-1 extracellular signal-regulated kinase signaling in Caenorhabditis elegans germline development.

Authors:  Min-Ho Lee; Mitsue Ohmachi; Swathi Arur; Sudhir Nayak; Ross Francis; Diane Church; Eric Lambie; Tim Schedl
Journal:  Genetics       Date:  2007-12       Impact factor: 4.562

Review 5.  Canonical RTK-Ras-ERK signaling and related alternative pathways.

Authors:  Meera V Sundaram
Journal:  WormBook       Date:  2013-07-11

6.  Modulation of KSR activity in Caenorhabditis elegans by Zn ions, PAR-1 kinase and PP2A phosphatase.

Authors:  John H Yoder; Huira Chong; Kun-Liang Guan; Min Han
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

7.  Starvation activates MAP kinase through the muscarinic acetylcholine pathway in Caenorhabditis elegans pharynx.

Authors:  Young-jai You; Jeongho Kim; Melanie Cobb; Leon Avery
Journal:  Cell Metab       Date:  2006-04       Impact factor: 27.287

8.  The C.elegans MAPK phosphatase LIP-1 is required for the G(2)/M meiotic arrest of developing oocytes.

Authors:  Alex Hajnal; Thomas Berset
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

9.  Genetic analysis of the Caenorhabditis elegans MAP kinase gene mpk-1.

Authors:  M R Lackner; S K Kim
Journal:  Genetics       Date:  1998-09       Impact factor: 4.562

Review 10.  Surface signaling in pathogenesis.

Authors:  P E Kolattukudy; L M Rogers; D Li; C S Hwang; M A Flaishman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.